Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants.

Ljutic B, Ochs M, Messham B, Ming M, Dookie A, Harper K, Ausar SF.

Vaccine. 2012 Apr 19;30(19):2981-8. doi: 10.1016/j.vaccine.2012.02.038. Epub 2012 Feb 27.

PMID:
22381074
2.

Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine.

Bologa M, Kamtchoua T, Hopfer R, Sheng X, Hicks B, Bixler G, Hou V, Pehlic V, Yuan T, Gurunathan S.

Vaccine. 2012 Dec 14;30(52):7461-8. doi: 10.1016/j.vaccine.2012.10.076. Epub 2012 Nov 2.

PMID:
23123106
3.

Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study.

Brooks WA, Chang LJ, Sheng X, Hopfer R; PPR02 Study Team.

Vaccine. 2015 Aug 26;33(36):4610-7. doi: 10.1016/j.vaccine.2015.06.078. Epub 2015 Jul 2.

PMID:
26143615
4.

Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults.

Pauksens K, Nilsson AC, Caubet M, Pascal TG, Van Belle P, Poolman JT, Vandepapelière PG, Verlant V, Vink PE.

Clin Vaccine Immunol. 2014 May;21(5):651-60. doi: 10.1128/CVI.00807-13. Epub 2014 Mar 5.

5.

Association between immunogenicity and adsorption of a recombinant Streptococcus pneumoniae vaccine antigen by an aluminum adjuvant.

Levesque PM, Foster K, de Alwis U.

Hum Vaccin. 2006 Mar-Apr;2(2):74-7. Epub 2006 Mar 3.

PMID:
17012880
6.

A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine.

Dagouassat N, Robillard V, Haeuw JF, Plotnicky-Gilquin H, Power UF, Corvaïa N, Nguyen T, Bonnefoy JY, Beck A.

Vaccine. 2001 Jul 20;19(30):4143-52.

PMID:
11457539
7.

Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.

Ren D, Almudevar AL, Pichichero ME.

Hum Vaccin Immunother. 2015;11(2):489-97. doi: 10.4161/21645515.2014.990861.

8.
9.

Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults.

Kamtchoua T, Bologa M, Hopfer R, Neveu D, Hu B, Sheng X, Corde N, Pouzet C, Zimmermann G, Gurunathan S.

Vaccine. 2013 Jan 2;31(2):327-33. doi: 10.1016/j.vaccine.2012.11.005. Epub 2012 Nov 12.

PMID:
23153437
10.

Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.

Mahboubi A, Fazeli MR, Dinarvand R, Samadi N, Sharifzadeh M, Ilka H, Azadi S, Soleimanian R, Kalkouei H, Hajikhanmirzaei R, Valadkhani M.

Iran J Immunol. 2008 Sep;5(3):163-70. doi: IJIv5i3A4.

11.

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials.

Leroux-Roels I, Devaster JM, Leroux-Roels G, Verlant V, Henckaerts I, Moris P, Hermand P, Van Belle P, Poolman JT, Vandepapelière P, Horsmans Y.

Vaccine. 2015 Jan 15;33(4):577-84. doi: 10.1016/j.vaccine.2013.10.052. Epub 2013 Oct 29.

12.

Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.

Radosević K, Rodriguez A, Mintardjo R, Tax D, Bengtsson KL, Thompson C, Zambon M, Weverling GJ, Uytdehaag F, Goudsmit J.

Vaccine. 2008 Jul 4;26(29-30):3640-6. doi: 10.1016/j.vaccine.2008.04.071. Epub 2008 May 15.

PMID:
18514980
13.

Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model.

Verhoeven D, Xu Q, Pichichero ME.

Vaccine. 2014 May 30;32(26):3205-10. doi: 10.1016/j.vaccine.2014.04.004. Epub 2014 Apr 13.

PMID:
24731814
14.

A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.

Denoël P, Philipp MT, Doyle L, Martin D, Carletti G, Poolman JT.

Vaccine. 2011 Jul 26;29(33):5495-501. doi: 10.1016/j.vaccine.2011.05.051. Epub 2011 May 30.

15.

Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.

Iyer V, Hu L, Liyanage MR, Esfandiary R, Reinisch C, Meinke A, Maisonneuve J, Volkin DB, Joshi SB, Middaugh CR.

J Pharm Sci. 2012 Sep;101(9):3078-90. doi: 10.1002/jps.23175. Epub 2012 Apr 26.

PMID:
22538529
16.

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.

Berthold I, Pombo ML, Wagner L, Arciniega JL.

Vaccine. 2005 Mar 14;23(16):1993-9.

PMID:
15734073
17.

Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.

Romero Méndez IZ, Shi Y, HogenEsch H, Hem SL.

Vaccine. 2007 Jan 15;25(5):825-33. Epub 2006 Sep 25.

PMID:
17014935
18.

The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.

Chen L, Xu M, Wang ZY, Chen BW, Du WX, Su C, Shen XB, Zhao AH, Dong N, Wang YJ, Wang GZ.

FEMS Immunol Med Microbiol. 2010 Jun 1;59(1):42-52. doi: 10.1111/j.1574-695X.2010.00660.x. Epub 2010 Feb 17.

19.

Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits.

Chang M, Shi Y, Nail SL, HogenEsch H, Adams SB, White JL, Hem SL.

Vaccine. 2001 Apr 6;19(20-22):2884-9.

PMID:
11282199
20.

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.

Morefield GL, Sokolovska A, Jiang D, HogenEsch H, Robinson JP, Hem SL.

Vaccine. 2005 Feb 18;23(13):1588-95.

PMID:
15694511

Supplemental Content

Support Center